Exclusive Summary

• First-line guideline-recommended topical NSAID for osteoarthritis (OA) and musculoskeletal pain, effectively circumventing GI side effects and targeting over 500 million globally affected patients.
• High technical barrier in cataplasm (hydrogel patch) formulations, offering immense competitive differentiation against traditional acrylic/rubber patches in global markets through distinct cooling effects and superior skin tolerability.
• Fully off-patent formulation backed by China's highly integrated supply chain, providing broad-market distributors with premium quality alternatives at significant cost advantages and substantial profit margins.